Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-09-27

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for haloperidol decanoate from Fresenius Kabi USA, LLC. This action relates to continued approval of a long-acting injec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)